Gornoslaskie Centrum Mwdyczne
- Address
- lock Available on a paid plan
Gornoslaskie Centrum Medyczne - Cardiovascular Research Center
Gornoslaskie Centrum Medyczne is a specialized cardiovascular research facility focusing on advanced interventional cardiology and antithrombotic therapy strategies. The center demonstrates particular expertise in managing complex patient populations requiring both percutaneous coronary intervention (PCI) and long-term anticoagulation therapy.
- Novel antithrombotic regimens for atrial fibrillation patients undergoing coronary stenting procedures
- Optimization of bleeding risk management in patients requiring dual or triple antithrombotic therapy
- Advanced interventional cardiology techniques with drug-eluting stent platforms
The center's research portfolio emphasizes patient safety optimization in high-risk cardiovascular populations, particularly those with atrial fibrillation requiring coronary revascularization. Their clinical trials investigate innovative approaches to balance the dual challenges of preventing major adverse cardiac and cerebral events while minimizing bleeding complications through streamlined medication regimens and the strategic use of direct oral anticoagulants.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 7 therapeutic areas and 15 of 48 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 43 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 28 by active trials.
lock +27 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Agencja Badań Medycznych5trials
lock +9 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gornoslaskie Centrum Mwdyczne
lock Showing 1 of 47 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety, and tolerability of intravenous ganaxolone added to standard of care in refractory status epilepticus | Marinus Pharmaceuticals Inc. | Phase III | Not Recruiting | Nov 2023 | Apr 2024 |
IMP list
lock Showing 1 of 48 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 6 | Unknown | 2022-02-07 | 2025-11-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.